Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial

@inproceedings{Stein2015DoesGE,
  title={Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial},
  author={Mark A. Stein and Vanja Sikirica and Margaret D Weiss and Brigitte Robertson and Andrew Lyne and Jeffrey H. Newcorn},
  booktitle={CNS drugs},
  year={2015}
}
BACKGROUND In clinical trials of medications to treat attention-deficit/hyperactivity disorder (ADHD) in children, effects on functional impairment have been less well-studied than changes in ADHD symptoms. OBJECTIVE Data regarding functional impairment were analyzed from a multicenter, double-blind, placebo-controlled study of guanfacine extended release (GXR) in children with ADHD, using the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P). The correspondence of changes in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
6 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Validation of the Weiss Functional Impairment Rating Scale—Parent Report Form in attention deficit/hyperactivity disorder

  • K Gajria, E Livote, V Sikirica, K Reilly, MH. Erder
  • Eur Neuropsychopharmacol. 2014;24(Suppl 2):S711
  • 2014
2 Excerpts

Similar Papers

Loading similar papers…